Ardelyx (Nasdaq: ARDX) is a biopharmaceutical company dedicated to developing first-in-class medicines that improve the lives of people living with kidney disease and gastrointestinal conditions. The company's lead approved product, XPHOZAH (tenapanor), is an FDA-approved treatment for hyperphosphatemia in adults with chronic kidney disease on dialysis.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountCreate a free account to see full funding history, valuations, and investor participation.
Create Free AccountCreate a free account to see which investors have funded this company.
Create Free Account